Effect of Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation on Liver Function and Immune Function in Patients with Hepatocellular Carcinoma

Objectives. To investigate the effects of transcatheter arterial chemoembolization (TACE) combined with radiofrequency ablation (RFA) on liver function and immune function in patients with hepatocellular carcinoma (HCC). Methods. From December 2016 to January 2019, patients with primary liver cancer...

Full description

Saved in:
Bibliographic Details
Main Authors: Yan Zhou, Ying Qian, Weiming Xiong, Naijun Yan, Bing Hu, Zhiyuan Xiong, Weixin He
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Emergency Medicine International
Online Access:http://dx.doi.org/10.1155/2022/4842370
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849685969685446656
author Yan Zhou
Ying Qian
Weiming Xiong
Naijun Yan
Bing Hu
Zhiyuan Xiong
Weixin He
author_facet Yan Zhou
Ying Qian
Weiming Xiong
Naijun Yan
Bing Hu
Zhiyuan Xiong
Weixin He
author_sort Yan Zhou
collection DOAJ
description Objectives. To investigate the effects of transcatheter arterial chemoembolization (TACE) combined with radiofrequency ablation (RFA) on liver function and immune function in patients with hepatocellular carcinoma (HCC). Methods. From December 2016 to January 2019, patients with primary liver cancer who could not be operated on were selected as the study subjects. 170 patients were randomly divided into two groups. The control group was treated with transcatheter arterial chemoembolization (n = 85). The patients in the observation group were treated with transcatheter arterial chemoembolization combined with radiofrequency ablation (n = 85). The clinical effects of the two groups were analyzed. The changes of liver function and immune function were detected by automatic biochemical analyzer before and after treatment. The changes of hypoxia inducible factor-1 (HIF1) alpha and vascular endothelial growth factor (VEGF) levels before and after treatment were analyzed by enzyme-linked immunosorbent assay (ELISA). Results. The total effective rate in the observation group was significantly higher than that in the control group (P<0.05). After treatment, serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), CD8+, HIF1 alpha, and VEGF decreased significantly (P<0.05), while levels of total bilirubin, direct bilirubin, indirect bilirubin, CD3+, CD4+, and CD4+/CD8+ increased significantly (P<0.05). The changes of the above indexes in the observation group were more significant than those in the control group (P<0.05). Conclusion. Hepatic arterial chemoembolization combined with radiofrequency ablation has a significant effect on liver function and immune function in patients with liver cancer, which may be related to the abnormal levels of HIF1α and vascular endothelial growth factor.
format Article
id doaj-art-bc0820a9bfdd4ec490cd99ee6106ebf0
institution DOAJ
issn 2090-2859
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Emergency Medicine International
spelling doaj-art-bc0820a9bfdd4ec490cd99ee6106ebf02025-08-20T03:22:53ZengWileyEmergency Medicine International2090-28592022-01-01202210.1155/2022/4842370Effect of Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation on Liver Function and Immune Function in Patients with Hepatocellular CarcinomaYan Zhou0Ying Qian1Weiming Xiong2Naijun Yan3Bing Hu4Zhiyuan Xiong5Weixin He6Department of Liver Disease and InfectionThe First College of Clinical Medical ScienceDepartment of Liver Disease and InfectionDepartment of Liver Disease and InfectionDepartment of Liver Disease and InfectionDepartment of Liver Disease and InfectionDepartment of Liver Disease and InfectionObjectives. To investigate the effects of transcatheter arterial chemoembolization (TACE) combined with radiofrequency ablation (RFA) on liver function and immune function in patients with hepatocellular carcinoma (HCC). Methods. From December 2016 to January 2019, patients with primary liver cancer who could not be operated on were selected as the study subjects. 170 patients were randomly divided into two groups. The control group was treated with transcatheter arterial chemoembolization (n = 85). The patients in the observation group were treated with transcatheter arterial chemoembolization combined with radiofrequency ablation (n = 85). The clinical effects of the two groups were analyzed. The changes of liver function and immune function were detected by automatic biochemical analyzer before and after treatment. The changes of hypoxia inducible factor-1 (HIF1) alpha and vascular endothelial growth factor (VEGF) levels before and after treatment were analyzed by enzyme-linked immunosorbent assay (ELISA). Results. The total effective rate in the observation group was significantly higher than that in the control group (P<0.05). After treatment, serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), CD8+, HIF1 alpha, and VEGF decreased significantly (P<0.05), while levels of total bilirubin, direct bilirubin, indirect bilirubin, CD3+, CD4+, and CD4+/CD8+ increased significantly (P<0.05). The changes of the above indexes in the observation group were more significant than those in the control group (P<0.05). Conclusion. Hepatic arterial chemoembolization combined with radiofrequency ablation has a significant effect on liver function and immune function in patients with liver cancer, which may be related to the abnormal levels of HIF1α and vascular endothelial growth factor.http://dx.doi.org/10.1155/2022/4842370
spellingShingle Yan Zhou
Ying Qian
Weiming Xiong
Naijun Yan
Bing Hu
Zhiyuan Xiong
Weixin He
Effect of Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation on Liver Function and Immune Function in Patients with Hepatocellular Carcinoma
Emergency Medicine International
title Effect of Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation on Liver Function and Immune Function in Patients with Hepatocellular Carcinoma
title_full Effect of Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation on Liver Function and Immune Function in Patients with Hepatocellular Carcinoma
title_fullStr Effect of Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation on Liver Function and Immune Function in Patients with Hepatocellular Carcinoma
title_full_unstemmed Effect of Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation on Liver Function and Immune Function in Patients with Hepatocellular Carcinoma
title_short Effect of Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation on Liver Function and Immune Function in Patients with Hepatocellular Carcinoma
title_sort effect of transcatheter arterial chemoembolization combined with radiofrequency ablation on liver function and immune function in patients with hepatocellular carcinoma
url http://dx.doi.org/10.1155/2022/4842370
work_keys_str_mv AT yanzhou effectoftranscatheterarterialchemoembolizationcombinedwithradiofrequencyablationonliverfunctionandimmunefunctioninpatientswithhepatocellularcarcinoma
AT yingqian effectoftranscatheterarterialchemoembolizationcombinedwithradiofrequencyablationonliverfunctionandimmunefunctioninpatientswithhepatocellularcarcinoma
AT weimingxiong effectoftranscatheterarterialchemoembolizationcombinedwithradiofrequencyablationonliverfunctionandimmunefunctioninpatientswithhepatocellularcarcinoma
AT naijunyan effectoftranscatheterarterialchemoembolizationcombinedwithradiofrequencyablationonliverfunctionandimmunefunctioninpatientswithhepatocellularcarcinoma
AT binghu effectoftranscatheterarterialchemoembolizationcombinedwithradiofrequencyablationonliverfunctionandimmunefunctioninpatientswithhepatocellularcarcinoma
AT zhiyuanxiong effectoftranscatheterarterialchemoembolizationcombinedwithradiofrequencyablationonliverfunctionandimmunefunctioninpatientswithhepatocellularcarcinoma
AT weixinhe effectoftranscatheterarterialchemoembolizationcombinedwithradiofrequencyablationonliverfunctionandimmunefunctioninpatientswithhepatocellularcarcinoma